Home › Kanser sa Suso › New Mexico › Albuquerque

Pag-aaral pangklinika para sa Kanser sa Suso sa Albuquerque, NM

Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Albuquerque. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Nagre-recruitPhase 3

Presbyterian Medical Group, Albuquerque

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Lovelace Medical Center-Saint Joseph Square, Albuquerque
University of New Mexico Cancer Center, Albuquerque
Lovelace Women's Hospital, Albuquerque
at 1 pa

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Nagre-recruitPhase 2

The University of New Mexico, Albuquerque

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07102381

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Nagre-recruitPhase 3

Presbyterian Kaseman Hospital ( Site 0072), Albuquerque
University of New Mexico Comprehensive Cancer Center ( Site 0047), Albuquerque

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07060807

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Nagre-recruitPhase 3

Research Site, Albuquerque

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06103864

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Nagre-recruitPhase 3

Lovelace Medical Center - Saint Joseph Square, Albuquerque
Lovelace Women's Hospital, Albuquerque
Presbyterian Kaseman Hospital, Albuquerque
at 1 pa

Edad 60 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06377852

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Nagre-recruit

New Mexico Oncology & Hematology Consultants, Albuquerque

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07214532

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Nagre-recruitPhase 3

Exigent Research LLC/New Mexico Oncology Hematology Consultants Ltd., Albuquerque

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06492616

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Nagre-recruitPhase 1/2

Research Site, Albuquerque

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05123482

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Nagre-recruitPhase 3

University of New Mexico Cancer Center, Albuquerque
Presbyterian Kaseman Hospital, Albuquerque

Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Nagre-recruitPhase 3

Presbyterian Kaseman Hospital, Albuquerque

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT05696626

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Nagre-recruitPhase 3

University of New Mexico Cancer Center, Albuquerque

Edad 50 hanggang 70 · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT04852887

SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers

Nagre-recruit

University of New Mexico, Albuquerque

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 7, 2026 · NCT06896474

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral

Lovelace Medical Center-Saint Joseph Square, Albuquerque
University of New Mexico Cancer Center, Albuquerque
Lovelace Women's Hospital, Albuquerque
at 1 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Albuquerque

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Nagre-recruitPhase 3

University of New Mexico Cancer Center, Albuquerque

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2025 · NCT03418961

BostonGene and Exigent Genomic INsight Study

Nagre-recruitObservasyonal na pag-aaral

New Mexico Cancer Center, Albuquerque

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2025 · NCT06272864

Pag-aaral para sa Kanser sa Suso sa ibang lungsod

Iba pang pag-aaral sa Albuquerque

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.